PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors

KJ Dedes, D Wetterskog, AM Mendes-Pereira… - Science translational …, 2010 - science.org
PTEN (phosphatase and tensin homolog) loss of function is the most common genetic
aberration in endometrioid endometrial carcinomas. In addition to its well-described role in cell …

Emerging therapeutic targets in endometrial cancer

KJ Dedes, D Wetterskog, A Ashworth… - Nature reviews Clinical …, 2011 - nature.com
Endometrial cancer comprises a heterogeneous group of tumors, with distinct risk factors,
clinical presentation, histopathological features and molecular characteristics. Currently, …

Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer …

…, W Polkowski, KJ Dedes, M Niewald, J Blohmer… - bmj, 2020 - bmj.com
Objective To determine whether risk adapted intraoperative radiotherapy, delivered as a
single dose during lumpectomy, can effectively replace postoperative whole breast external …

Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations

KJ Dedes, PM Wilkerson, D Wetterskog, B Weigelt… - Cell cycle, 2011 - Taylor & Francis
Utilizing the concept of synthetic lethality has provided new opportunities for the development
of targeted therapies, by allowing the targeting of loss of function genetic aberrations. In …

[HTML][HTML] ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian Carcinomas

EP Samartzis, A Noske, KJ Dedes, D Fink… - International journal of …, 2013 - mdpi.com
Endometriosis is a common gynecological disease affecting 6%–10% of women of reproductive
age and is characterized by the presence of endometrial-like tissue in localizations …

Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer

KJ Dedes, R Natrajan, MB Lambros, FC Geyer… - European journal of …, 2011 - Elsevier
Down-regulation of Drosha and Dicer has been suggested to be of prognostic value in some
cancers. The aims of our study were to investigate the down-regulation of Drosha and Dicer …

[HTML][HTML] Loss of ARID1A expression sensitizes cancer cells to PI3K-and AKT-inhibition

EP Samartzis, K Gutsche, KJ Dedes, D Fink, M Stucki… - Oncotarget, 2014 - ncbi.nlm.nih.gov
ARID1A mutations are observed in various tumors, including ovarian clear cell (OCCC) and
endometrioid carcinomas, endometrial, and breast carcinomas. They commonly result in …

Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer

MD Forster, KJ Dedes, S Sandhu, S Frentzas… - Nature reviews Clinical …, 2011 - nature.com
Background. A 58-year-old woman presented with metastatic endometrioid endometrial
adenocarcinoma after being previously treated with surgery and adjuvant radiotherapy for early-…

Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast

…, EP Samartzis, KJ Dedes, J Frankum… - The Journal of …, 2014 - Wiley Online Library
Micropapillary carcinoma ( MPC ) is a rare histological special type of breast cancer, characterized
by an aggressive clinical behaviour and a pattern of copy number aberrations ( CNAs …

Effect of delayed targeted intraoperative radiotherapy vs whole-breast radiotherapy on local recurrence and survival: long-term results from the TARGIT-A randomized …

…, W Polkowski, KJ Dedes, M Niewald, J Blohmer… - JAMA …, 2020 - jamanetwork.com
Importance Conventional adjuvant radiotherapy for breast cancer given daily for several
weeks is onerous and expensive. Some patients may be obliged to choose a mastectomy …